Shopping Cart
- Remove All
Your shopping cart is currently empty
Acyl-Coenzyme A: cholesterol acyltransferase-1 and -2 (ACAT-1 and ACAT-2) catalyze the formation of cholesterol esters from cholesterol and long chain fatty acyl-coenzyme A, and may play a role in the development of atherosclerosis. CAY10486 inhibits human ACAT-1 and ACAT-2 equally with an IC50 value of approximately 60 μM. It also inhibits copper-mediated oxidation of low density lipoproteins by about 28% at a concentration of 3 μM.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | $108 | 35 days | |
| 10 mg | $198 | 35 days | |
| 25 mg | $485 | 35 days | |
| 50 mg | $792 | 35 days |
| Description | Acyl-Coenzyme A: cholesterol acyltransferase-1 and -2 (ACAT-1 and ACAT-2) catalyze the formation of cholesterol esters from cholesterol and long chain fatty acyl-coenzyme A, and may play a role in the development of atherosclerosis. CAY10486 inhibits human ACAT-1 and ACAT-2 equally with an IC50 value of approximately 60 μM. It also inhibits copper-mediated oxidation of low density lipoproteins by about 28% at a concentration of 3 μM. |
| Molecular Weight | 325.36 |
| Formula | C19H19NO4 |
| Cas No. | 615264-52-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | Ethanol: 20 mg/mL (61.47 mM), Sonication is recommended. DMSO:PBS (pH 7.2)(1:5): 0.5 mg/mL (1.54 mM), Sonication is recommended. DMSO: 30 mg/mL (92.21 mM), Sonication is recommended. DMF: 30 mg/mL (92.21 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
Ethanol/DMSO/DMF
| ||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.